https://www.marketscreener.com/quote/stock/FORMA-THERAPEUTICS-HOLDIN-108665623/news/Forma-Therapeutics-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-Evaluating-FT-7051-for-32235806/?utm_source=telegram&utm_medium=social&utm_campaign=share